TickerFactsScreenerDevelopers

Forte Biosciences, Inc. (FBRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $4.20M2015: $8.15M2016: $5.51M2017: $35.93M2018: $40.81M2019: $6.94M2020: $58.77M2021: $42.04M2022: $41.10M2023: $37.12M2024: $22.24M2025: $76.96M$76.96M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$76.96M+246.0%
2024$22.24M-40.1%
2023$37.12M-9.7%
2022$41.10M-2.2%
2021$42.04M-28.5%
2020$58.77M+746.9%
2019$6.94M-83.0%
2018$40.81M+13.6%
2017$35.93M+552.1%
2016$5.51M-32.4%
2015$8.15M+93.9%
2014$4.20M—